We are live on ! Find out more

Small Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
AMRN icon
1
Amarin
AMRN
$478M
$478M $11.31 0.62%
PLX icon
2
Protalix BioTherapeutics
PLX
$257M
$257M $3.03 0.66%

Small Cap Drug Manufacturers - General Stocks at a Glance

Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.

There are 2 small cap Drug Manufacturers - General stocks — companies in the Drug Manufacturers - General industry with a market cap between $250M and $2B — worth a combined $736M.

The largest by market cap are Amarin (AMRN) at $478M and Protalix BioTherapeutics (PLX) at $257M.

Among institutional investors, Protalix BioTherapeutics (PLX) drew the most net new fund positions in Q3 2026: 18 funds opened new positions, taking total fund holders up 3 (2.9%) quarter-over-quarter.

  • Combined market cap: $736M across 2 stocks.
  • Small Cap: market cap between $250M and $2B.
  • Largest constituent: Amarin (AMRN), $478M market cap.
  • Most net new fund positions in Q3 2026: Protalix BioTherapeutics (PLX), +3 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.